Pharmacists mostly compliant
January 9, 2013
MORE than 90% of practitioners
were shown to be compliant
with the Pharmacy Board of
Australia’s registration standards,
according to the results of the
Practitioner Audit Pilot Report-
Phase One.
This majority result, according to
the Pharmacy Board, indicates that
registrants are aware and engaged
with the requirements
of the registration standards for the
pharmacy profession.
In terms of a breakdown, the
report found that two percent of
practitioners selected for the audit
changed their registration status to
non-practising.
Of this group the majority were
found to be not practising in
Australia and as such, were not
required to participate or provide
evidence of compliance with the
registration standards.
“This highlighted a need to
increase awareness among
practitioners about the
most appropriate registration type
for this group,” the report said.
In addition, during the audit five
percent of the practitioners fell
short of one or more of the registration
standards and were thus referred to
the Board for review.
“The levels of non-compliance
varied and we have identified two
areas where clarification and
communication of requirements is
required,” the report said.
“The first was how to assess
ROP of overseas registrants and the
second was to develop criteria for
assessing breaches of the CRC
depending on the severity of
noncompliance,” the report added.
Meanwhile two percent of
participants were found not
participating in CPD/ROP and 1%
did not renew their registration.
Moving forward, the second
phase of the pilot is currently in
progress with optometry, pharmacy
and chiropractic professions under
AHPRA’s microscope.
Practitioners will be
randomly selected across these
three professions when they
apply to renew their registration
for the 2012-13 period.
Practitioners selected to
participate will be audited for
compliance against their Board’s
registration standards:
criminal history, professional
indemnity insurance, recency
of practice and continuing
professional development.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jan 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jan 13
